Robert Adams to Antisickling Agents
This is a "connection" page, showing publications Robert Adams has written about Antisickling Agents.
Connection Strength
0.757
-
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016 Feb 13; 387(10019):661-670.
Score: 0.519
-
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. Br J Haematol. 2021 11; 195(4):612-620.
Score: 0.191
-
Stroke prevention and treatment in sickle cell disease. Arch Neurol. 2001 Apr; 58(4):565-8.
Score: 0.047